What does the abolition of NHS England mean for your market access and NHS Engagement strategy? How will the changes at national and integrated care board (ICB) level impact launch strategies?
We invite you to join us for a series of special Q&A sessions with senior decision makers in the NHS, to explore what these changes mean on the ground now and what we can expect going forward. The first of these NHS Whispers specials, will be on Thursday 3rd April at 12.00pm (BST)/13.00pm (CEST).
Join us live as Prof. Phil Richardson (Chief Innovation Officer & Chair, Mtech Access – Powered by Petauri and former ICS system leader) puts your questions to:
- Tim Goodson (Executive Officer, Dorset General Practice Alliance and former ICS system leader)
- Ashleigh Boreham (Deputy Director Partnerships, Research and Innovation, NHS Dorset and formerly Deputy Chief Officer Strategy and Transformation, NHS Dorset)
On 13th March, UK Prime Minister Sir Keir Starmer announced the abolition of NHS England (NHSE) to “cut bureaucracy” and bring management of the health service “back into democratic control”. The day before, Sir Jim Mackey, interim CEO of NHSE, announced a significant restructuring of ICBs, mandating a 50% reduction in their costs. This will lead to the merger of several ICBs and a substantial reduction in leadership roles. The restructuring is expected to have significant repercussions for the Pharmaceutical and Medtech industries. Learn more about the announcement and our initial thoughts on the implications for industry here. In response, we are hosting a series of NHS Whispers specials to gain early perspectives and direct insights on what this means for the NHS and industry, from those responding to these changes and driving decision-making in the NHS.
This first session will be conducted live under ‘Chatham House Rules’, to enable our speakers to share their views openly in these changing times and facilitate a live, active discussion. We will be taking questions directly from you in the session. You can also submit questions in advance when you register. To enable this active discussion, the webinar will not be recorded, so please attend live with your questions!
What questions will you put forward? The session will be shaped by the questions we receive in advance and on the day, by the live audience. We anticipate, this could include:
- How will the abolition of NHSE affect market access in England?
- What does the restructuring on ICBs mean for Pharma market access?
- How quickly can we expect to see changes on the ground?
- What will this mean for the future of ICBs?
- What will this mean for specialised commissioning and the devolution of specialised services to ICBs?
- Where and how will this change decision-making?
- How should Pharma and Medtech be adapting their strategies?
Please register and add your question to the list.
About our speakers
Tim Goodson (Executive Officer, Dorset General Practice Alliance and former Integrated Care System [ICS] system leader)
Tim Goodson spent his career working within the NHS helping to improve services for patients. Most recently Tim was the ICS lead for Dorset as well as being the Chief Executive for Dorset Clinical Commissioning Group (CCG) for 9 years. These roles enabled him to take a leadership role both locally and nationally, enabling Dorset to be at the forefront of promoting an integrated approach across health and social care.
Under Tim’s stewardship, Dorset undertook a comprehensive Clinical Service Review that set out the roadmap for how Dorset wanted to transform health services to improve patient care, whilst at the same time offering a sustainable solution for the NHS in Dorset. During Tim’s career he has held a broad range of executive responsibilities including the post of Director of Finance for three Primary Care Trusts also spanning 9 years. Tim now runs his own company providing consultancy services and hands on support to boards, and is also a Trustee of a local hospice.
Ashleigh Boreham (Deputy Director Partnerships, Research and Innovation, NHS Dorset and formerly Deputy Chief Officer Strategy and Transformation, NHS Dorset)
Ashleigh is a highly experienced healthcare leader with a career spanning over two decades. In addition to his role as Deputy Director Partnerships, Research and Innovation, his current portfolio also includes his role as Programme Director for Oral Health and the Medical School, in addition to leading on Creative Health and on Health for the Armed Forces Community.
He previously served for 27 years in the Regular Army, deploying to the Balkans, Sierra Leone, Kenya and Oman before joining the NHS in 2020. He was Head of Medical Operations in Germany and Afghanistan, and commanded two Field Hospitals, deploying to Iraq and Kosovo in this role. He was awarded the Order of St John in 2001. Previous appointments included Corps Colonel and Head of Career Management for the Army Medical Services, leading strategic workforce planning and medical training.
We invite you to put your questions to Ashley and Tim in this special session. Register now to join us live:
The webinar is free and open to all market access, patient access, field-based, and other healthcare professional‑facing teams in Pharmaceutical and Medtech companies. Some colleagues from other organisations may attend at the discretion of Mtech Access – Powered by Petauri.
